492 related articles for article (PubMed ID: 19635397)
1. Systemic therapies for squamous cell carcinoma of the head and neck.
Kurtin SE
Semin Oncol Nurs; 2009 Aug; 25(3):183-92. PubMed ID: 19635397
[TBL] [Abstract][Full Text] [Related]
2. Surgical management of head and neck carcinoma.
Scarpa R
Semin Oncol Nurs; 2009 Aug; 25(3):172-82. PubMed ID: 19635396
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy options for patients with metastatic or recurrent squamous cell carcinoma of the head and neck.
Colevas AD
J Clin Oncol; 2006 Jun; 24(17):2644-52. PubMed ID: 16763278
[TBL] [Abstract][Full Text] [Related]
4. Impact of tumor board recommendations on treatment outcome for locally advanced head and neck cancer.
Nguyen NP; Vos P; Lee H; Borok TL; Karlsson U; Martinez T; Welsh J; Cohen D; Hamilton R; Nguyen N; Nguyen LM; Vinh-Hung V
Oncology; 2008; 75(3-4):186-91. PubMed ID: 18841033
[TBL] [Abstract][Full Text] [Related]
5. Supportive care in head and neck oncology.
de Castro G; Guindalini RS
Curr Opin Oncol; 2010 May; 22(3):221-5. PubMed ID: 20186057
[TBL] [Abstract][Full Text] [Related]
6. Randomized trial of postoperative reirradiation combined with chemotherapy after salvage surgery compared with salvage surgery alone in head and neck carcinoma.
Janot F; de Raucourt D; Benhamou E; Ferron C; Dolivet G; Bensadoun RJ; Hamoir M; Géry B; Julieron M; Castaing M; Bardet E; Grégoire V; Bourhis J
J Clin Oncol; 2008 Dec; 26(34):5518-23. PubMed ID: 18936479
[TBL] [Abstract][Full Text] [Related]
7. Radiation therapy for head and neck cancers.
Mallick I; Waldron JN
Semin Oncol Nurs; 2009 Aug; 25(3):193-202. PubMed ID: 19635398
[TBL] [Abstract][Full Text] [Related]
8. The challenging integration of platinum compounds, taxanes, and molecular-targeted therapies in the multidisciplinary treatment of squamous cell carcinoma of the head and neck.
Awada A; Ismael G
Curr Opin Oncol; 2007 May; 19(3):177-9. PubMed ID: 17414633
[TBL] [Abstract][Full Text] [Related]
9. Induction chemotherapy in the management of squamous cell carcinoma of the head and neck.
Roman E; Raez LE; Santos ES
Expert Rev Anticancer Ther; 2006 Sep; 6(9):1205-15. PubMed ID: 17020455
[TBL] [Abstract][Full Text] [Related]
10. Altered radiation therapy fractionation, chemoradiation, and patient selection for the treatment of head and neck squamous carcinoma.
Rosenthal DI; Ang KK
Semin Radiat Oncol; 2004 Apr; 14(2):153-66. PubMed ID: 15095261
[TBL] [Abstract][Full Text] [Related]
11. Alteration of radiotherapy fractionation and concurrent chemotherapy: a new frontier in head and neck oncology?
Bernier J
Nat Clin Pract Oncol; 2005 Jun; 2(6):305-14. PubMed ID: 16264988
[TBL] [Abstract][Full Text] [Related]
12. Systemic therapy of head and neck cancer: most effective agents, areas of promise.
Urba SG; Forastiere AA
Oncology (Williston Park); 1989 Apr; 3(4):79-88; discussion 88, 90, 97-8. PubMed ID: 2701419
[TBL] [Abstract][Full Text] [Related]
13. Incidence and costs of treatment-related complications among patients with advanced squamous cell carcinoma of the head and neck.
Lang K; Sussman M; Friedman M; Su J; Kan HJ; Mauro D; Tafesse E; Menzin J
Arch Otolaryngol Head Neck Surg; 2009 Jun; 135(6):582-8. PubMed ID: 19528407
[TBL] [Abstract][Full Text] [Related]
14. Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer.
Haddad R; Sonis S; Posner M; Wirth L; Costello R; Braschayko P; Allen A; Mahadevan A; Flynn J; Burke E; Li Y; Tishler RB
Cancer; 2009 Oct; 115(19):4514-23. PubMed ID: 19634161
[TBL] [Abstract][Full Text] [Related]
15. Standard, and novel cytotoxic and molecular-targeted, therapies for HNSCC: an evidence-based review.
Murdoch D
Curr Opin Oncol; 2007 May; 19(3):216-21. PubMed ID: 17414639
[TBL] [Abstract][Full Text] [Related]
16. Current state-of-the-art for concurrent chemoradiation.
Bernier J
Semin Radiat Oncol; 2009 Jan; 19(1):3-10. PubMed ID: 19028339
[TBL] [Abstract][Full Text] [Related]
17. The expanding role of systemic therapy in head and neck cancer.
Cohen EE; Lingen MW; Vokes EE
J Clin Oncol; 2004 May; 22(9):1743-52. PubMed ID: 15117998
[TBL] [Abstract][Full Text] [Related]
18. Frequency of esophageal stenosis after simultaneous modulated accelerated radiation therapy and chemotherapy for head and neck cancer.
Lawson JD; Otto K; Grist W; Johnstone PA
Am J Otolaryngol; 2008; 29(1):13-9. PubMed ID: 18061826
[TBL] [Abstract][Full Text] [Related]
19. Emerging molecular targeted therapies in squamous cell carcinoma of the head and neck.
Gilbert J; Argiris A
Clin Adv Hematol Oncol; 2006 Aug; 4(8):611-9. PubMed ID: 17099619
[TBL] [Abstract][Full Text] [Related]
20. Management of squamous cell carcinoma of the head and neck: updated European treatment recommendations.
Ramos M; Benavente S; Giralt J
Expert Rev Anticancer Ther; 2010 Mar; 10(3):339-44. PubMed ID: 20214515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
